Skip to content

Author

Jennifer E. Amengual

We have 2 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Abstract B059: Patient-reported barriers to clinical trial enrollment: A site-level analysis of DCP-001 non-enrollees at an academic medical center

Understanding why eligible patients with cancer decline clinical trial participation is critical to developing targeted accrual interventions. DCP-001 is a National Cancer Institute (NCI) Division of Cancer Prevention protocol within the NCI Community Oncology Research Program (NCORP). The protocol systematically...

J. Kahn, M. Beauchemin, Erik Harden et al. · 0 citations
Open access Aug 2026

Post-treatment circulating tumor DNA in large B-cell lymphoma with an immunoglobulin-based assay: real-world outcomes.

A multicenter, retrospective study of patients with LBCL assessed in real time with a commercially available, immunoglobulin rearrangement-targeted ctDNA-MRD assay (clonoSEQM), finding post-treatment MRD after immunochemotherapy or chimeric antigen receptor T-cell (CAR-T) therapy was 15% versus 85% for detectable versu...

Patrick Gould, D. Coskey, Xin Ma et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.